AAAAAA

   
Results: 1-11 |
Results: 11
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: Correlation with galactomannan antigenemia
Authors: Petraitiene, R Petraitis, V Groll, AH Sein, T Piscitelli, S Candelario, M Field-Ridley, A Avila, N Bacher, J Walsh, TJ
Citation: R. Petraitiene et al., Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: Correlation with galactomannan antigenemia, ANTIM AG CH, 45(3), 2001, pp. 857-869
Geoelectrical and seismoacoustic anomalous signals jointly recorded close to an active fault system in Southern Apennines (Italy)
Authors: Cuomo, V Lapenna, V Macchiato, M Marson, I Paparo, G Patella, D Piscitelli, S
Citation: V. Cuomo et al., Geoelectrical and seismoacoustic anomalous signals jointly recorded close to an active fault system in Southern Apennines (Italy), PHYS CH P A, 25(3), 2000, pp. 255-261
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: Pharmacokinetic drug interactions and antiviral activity
Authors: Falloon, J Piscitelli, S Vogel, S Sadler, B Mitsuya, H Kavlick, MF Yoshimura, K Rogers, M LaFon, S Manion, DJ Lane, HC Masur, H
Citation: J. Falloon et al., Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: Pharmacokinetic drug interactions and antiviral activity, CLIN INF D, 30(2), 2000, pp. 313-318
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S29-S65
Robust statistical methods to discriminate extreme events in geoelectricalprecursory signals: Implications with earthquake prediction
Authors: Cuomo, V Di Bello, G Lapenna, V Piscitelli, S Telesca, I Macchiato, M Serio, C
Citation: V. Cuomo et al., Robust statistical methods to discriminate extreme events in geoelectricalprecursory signals: Implications with earthquake prediction, NAT HAZARDS, 21(2-3), 2000, pp. 247-261
Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis
Authors: Walsh, TJ Gonzalez, CE Piscitelli, S Bacher, JD Peter, J Torres, R Shetti, D Katsov, V Kligys, K Lyman, CA
Citation: Tj. Walsh et al., Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasis, J CLIN MICR, 38(6), 2000, pp. 2369-2373
Scale-invariance properties in seismicity of Southern Apennine Chain (Italy)
Authors: Lapenna, V Macchiato, M Piscitelli, S Teresca, L
Citation: V. Lapenna et al., Scale-invariance properties in seismicity of Southern Apennine Chain (Italy), PUR A GEOPH, 157(4), 2000, pp. 589-601
A pilot study of low-dose fludarabine in membranous nephropathy refractoryto therapy
Authors: Boumpas, DT Tassiulas, IO Fleisher, TA Vaughan, E Piscitelli, S Kim, Y Pucino, F Balow, JE Austin, HA
Citation: Dt. Boumpas et al., A pilot study of low-dose fludarabine in membranous nephropathy refractoryto therapy, CLIN NEPHR, 52(2), 1999, pp. 67-75
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Authors: Masur, H Kaplan, JE Holmes, KK Alston, BL Ampel, N Anderson, JR Baker, AC Barr, D Bartlett, JG Bennett, JE Benson, CA Bozzette, SA Chaisson, RE Crumpacker, CS Currier, JS Deyton, L Drew, WL Duncan, WR Eisinger, RW El-Sadr, W Feinberg, J Freedberg, KA Furrer, H Gnann, JW Goldberger, MJ Goldie, S Goosby, EP Gross, PA Hafner, R Havlir, D Hooton, TM Jabs, DA Jacobson, MA Janoff, E Kitahata, M Kovacs, JV Leport, C Levin, MJ Lopez, JC Marco, M Mayers, DL Melnick, DA Mofenson, LM Montaner, JSG Moore, R Neaton, J Nelson, C O'Neill, JF Palefsky, J Pau, A Phair, JP Piscitelli, S Polis, MA Quinn, TC Reiss, P Rimland, D Sears, CL Seeff, L Sepkowitz, KA Slama, TG Sloand, EM Spector, SA Thomas, DL Van Dyke, RB Watts, DH Wheat, LJ Whitcup, SM Williams, P Wright, TC Castro, KG DeCock, KM Dowell, SF Dworkin, MS Dykewicz, C Ellerbrock, T Hajjeh, R Holmberg, S Holtgrave, DR Jaffe, HW Jones, JL Juranek, DD Mast, E Navin, T Pellett, PE Reeves, WC Stewart, JA Villarino, ME Kaplan, JE
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, ANN INT MED, 131(11), 1999, pp. 873-908
Time dynamics of background noise in geoelectrical and geochemical signals: An application in a seismic area of Southern Italy
Authors: Di Bello, G Ragosta, M Heinicke, J Koch, U Lapenna, V Piscitelli, S Macchiato, M Martinelli, G
Citation: G. Di Bello et al., Time dynamics of background noise in geoelectrical and geochemical signals: An application in a seismic area of Southern Italy, NUOV CIM C, 21(6), 1998, pp. 609-629
Gabapentin does not alter single-dose lithium pharmacokinetics
Authors: Frye, MA Kimbrell, TA Dunn, RT Piscitelli, S Grothe, D Vanderham, E Cora-Locatelli, G Post, RM Ketter, TA
Citation: Ma. Frye et al., Gabapentin does not alter single-dose lithium pharmacokinetics, J CL PSYCH, 18(6), 1998, pp. 461-464
Risultati: 1-11 |